14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
JHX vs AMRZ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Amrize Ltd (AMRZ) captures the overall head-to-head institutional edge over James Hardie Industries plc (JHX) on higher Unified Composite conviction (43.5/100 HOLD vs. 50.0/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Options & Positioning), while JHX wins 4–2 across the 6-pillar growth and valuation breakdown. JHX trades at $26.48 (21.6x Forward P/E, 16.5% operating margin) versus AMRZ at $39.05 (15.6x Forward P/E, 15.7% operating margin).
Composite vs. Pillar Nuance: While JHX currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. AMRZ 43.5/100 HOLD), AMRZ captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (15.7% vs. 16.5% operating margin) and revenue trajectory (+2.2% vs. +23.7% YoY).
Technical & Structure Timing Caution: JHX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.5); meanwhile AMRZ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JHX vs AMRZ. Trailing 12-month operating profitability (JHX 16.5% vs AMRZ 15.7%) and valuation multiples (JHX 21.6x vs AMRZ 15.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Building Materials value chain with $21.3B market capitalization and 15.7% operating margin.
OpEx & R&D Reinvestment9.1% of Rev ($1.12B)
90D Engineering Disclosures0 Published
Investor FAQ JHX vs AMRZ Key Questions & Quantitative Answers
As of Nov 20, 2026, Amrize Ltd (AMRZ) captures the overall head-to-head institutional edge over James Hardie Industries plc (JHX) on higher Unified Composite conviction (43.5/100 HOLD vs. 50.0/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Options & Positioning), while JHX wins 4–2 across the 6-pillar growth and valuation breakdown. JHX trades at $26.48 (21.6x Forward P/E, 16.5% operating margin) versus AMRZ at $39.05 (15.6x Forward P/E, 15.7% operating margin). Composite vs. Pillar Nuance: While JHX currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. AMRZ 43.5/100 HOLD), AMRZ captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (15.7% vs. 16.5% operating margin) and revenue trajectory (+2.2% vs. +23.7% YoY). Technical & Structure Timing Caution: JHX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.5); meanwhile AMRZ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
JHX leads the Growth & Scale pillar: JHX posts +23.7% YoY revenue growth and +23.4% YoY earnings growth on $5.66B TTM revenue (37.6% gross margin, 16.5% operating margin), compared with AMRZ at +2.2% YoY revenue growth and +4.1% YoY earnings growth on $12.3B TTM revenue (24.8% gross margin, 15.7% operating margin). On trailing 12-month operating scale, JHX generates $5.66B in USD-normalized revenue versus $12.3B for AMRZ. In operating R&D and SG&A reinvestment, JHX deploys 21.1% of Rev ($1.20B) (0 90-day corporate R&D disclosures) versus 9.1% of Rev ($1.12B) (0 disclosures) for AMRZ.
AMRZ screens cheaper on headline valuation multiples. JHX trades at 21.6x Forward P/E, 46.2x Trailing P/E, 1.24x PEG, and 2.7x EV/Revenue (27.8% EBITDA margin), whereas AMRZ trades at 15.6x Forward P/E, 17.9x Trailing P/E, 1.17x PEG, and 2.3x EV/Revenue (8.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JHX (5.5% ROE) versus AMRZ (9.7% ROE) capital efficiency.
In options market volatility and institutional positioning, JHX carries 44.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 50% Vol realized risk). By comparison, AMRZ carries 36.9% implied volatility (9th %ile, Compressed (<25th %ile)), a 0.95x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (1.02β · 38% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.